Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Share options granted

Observe Medical ASA Board of Directors has on January 9 2020, as part of a long-term incentive plan, approved granting Björn Larsson (CEO in Observe Medical ASA) 60 000 series A options and 60 000 series B options. Each option, when exercised, will give the right to acquire one share in Observe Medical ASA. The options are granted without consideration.  The series A options are granted vest over a 3 year period, with 1/3 after 12 months, 1/3 after 24 months and the last third after 36 months. The series A option shares have a 12 month lock-up period tied to them. Options that have not

Fortum concludes the sale of its district heating business in Joensuu, Finland

FORTUM CORPORATION STOCK EXCHANGE RELEASE 10 JANUARY 2020 AT 14:35 EETRelease category: Other information disclosed according to the rules of the Exchange Fortum has today concluded the sale of its district heating business in Joensuu, Finland to Savon Voima Oyj, as announced on 20 December 2019. The total consideration of the sale on a debt- and cash-free basis is approximately EUR 530 million. Fortum will record a tax exempt capital gain of approximately EUR 430 million in the City Solutions segment’s first-quarter 2020 results. Fortum Corporation Ingela Ulfves, VP, IR and

Storebrand Bank ASA: New covered bond issuance

STOREBRAND BOLIGKREDITT AS, rated AAA (Stable) by S&P, has mandated Danske Bank, DNB Markets, Nordea Markets and SEB as joint lead managers for a potential NOK Covered Benchmark 4.5Y FRN issue due June 2024. The transaction, issued under the issuer’s MTN- program, is expected to be launched in the near future, subject to market conditions. Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients (all distribution channels). No PRIIPs key information document (KID) has been prepared as not deemed within scope. For further information,

Storebrand Boligkreditt AS: New covered bond issuance

STOREBRAND BOLIGKREDITT AS, rated AAA (Stable) by S&P, has mandated Danske Bank, DNB Markets, Nordea Markets and SEB as joint lead managers for a potential NOK Covered Benchmark 4.5Y FRN issue due June 2024. The transaction, issued under the issuer’s MTN- program, is expected to be launched in the near future, subject to market conditions. Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients (all distribution channels). No PRIIPs key information document (KID) has been prepared as not deemed within scope. For further information,

Redsense Medical AB enters 2020 with new orders, total order book value now MSEK 2

Following the turn of the year, Redsense Medical has during the first days of January received an influx of new orders to a combined value of more than MSEK 1.5; these new orders bring the Company’s current total order book value up to approximately MSEK 2. In the last quarters of 2019, the Company’s order backlog increased significantly as market demand kept rising. In response to this development, Redsense has previously announced a set of measures to strengthen production capacity and meet the growing demand. ”We are happy to see that we are continuing to receive orders at an

RhoVac receives approval in Germany and Belgium to start clinical phase IIb study in prostate cancer

RhoVac AB ("RhoVac") announces today, on 10[th] January 2020, that the company has received approval from Beligian FAMHP (Federal Agency for Medicines and Health Products) and German Federal Institute for Vaccines and Biomedicines for starting the clinical phase IIb study in prostate cancer, a multicenter study entitled RhoVac-002 ("BRaVac"). The phase IIb study is an international, multicenter study, which is expected to recruit more than 175 patients in EU, as well as in the United States. RhoVac has previously received approval Denmark and Finland.BRaVac is a randomized, placebo-

Acquisition of Colegio Joyfe

Internationella Engelska Skolan i Sverige Holdings II AB (”Internationella Engelska Skolan” or ”IES”) has as of today, 10 January 2020, through its wholly-owned Spanish subsidiary International Education Partnership S.L (”IEP”) acquired 100% of the shares in Colegio Joyfe, a private school in Madrid, Spain. Colegio Joyfe has 2,000 students aged from 3 to 18 years. It is a fee-paying bilingual private school which follows the Spanish curriculum. The school is located in eastern Madrid and has excellent premises including indoor and outdoor sport facilities. Anna Sörelius Nordenborg,

Andreas Johansson – the new CTO

Andreas Johansson will take over as CTO on January 13, 2020, taking the place of Anders Sjögren who held this position since spring 2017. Anders remains in Lumito's organisation as a senior adviser and will continue to contribute to the company's development.- I look forward to starting as Lumito’s CTO. This is an innovative, high-potential company, whose product can deliver enormous value to the market. I will work with continued technological development, with particular focus on the mix of software and hardware. Given my solid experience in systems design and product development, I

Authentic shirt signed by Bale and Giggs donated by Conotoxia Holding to support the GOCC

Once again, our Polish brand Cinkciarz.pl supports annual charity event - the Great Orchestra of Christmas Charity. This year, the Company donated to the auction a shirt that football supporters will desire to have!Official shirt of the National Football Team of Wales with autographs of Gareth Bale and other Welsh football stars along with their coach's signature Ryan Giggs - such a token cannot normally be bought, even for a substantial amount of money. However, thanks to fintech, it is possible to buy it by bidding in a charity auction dedicated to the Great Orchestra of Christmas

All aboard!!! Stena Estrid to set sail on Monday

Stena Line’s newest ferry to start service on Holyhead to Dublin route on Monday morning STENA LINE has confirmed that its newest ferry Stena Estridwill start service on the Holyhead to Dublin route on Monday morning (January 13). The ship’s maiden voyage will be the 8.55am crossing from Holyhead, while its first Dublin departure will be the 2.50pm sailing from Dublin Port. Stena Estridwill make two daily return trips on the route, as below: Ex-Holyhead Ex-Dublin0855hrs 1450hrs2030hrs 0215hrs A crossing time of three hours and 15 minutes will pass very quickly

BIMobject wins strategic deal in Southeast Asia by forming a joint venture with Thailand's largest industrial conglomerate SCG/CPAC

BIMobject today announces a strategic partnership with CPAC, a subsidiary to SCG, a cement and building materials manufacturing company valued USD 15.6 billion. The partnership is formed as a joint venture (JV), where BIMobject secures minimum USD 500,000 annually during the first five years of operation in license fees.  The cooperation is a part of BIMobject’s strategy and aims to establish the technology and platform in Asia. Together with CPAC we have seen that adoption of BIM is now accelerating and that BIMobject’s technology and platform is a potent solution to the needs of the

Invitation to Bulten's Capital Markets Day 2020

Bulten has the pleasure of inviting financial analysts, investors and media to a Capital Markets Day in Stockholm on 20 February 2020 in Stockholm.During the afternoon, we will provide an update on Bulten's strategy for sustainable growth, financial development and focus areas. The presentations will be held by Anders Nyström, CEO, Helena Wennerström, CFO, and by other representatives from the company's management. The event will take place in the Match Palace (Tändstickspalatset), Västra Trädgårdsgatan 15, Stockholm on 20 February 2020, 13:00 - 17:00 CET. Lunch is served from 12:00.

Save the date – Pandox capital markets day 2020

Pandox AB (publ) invites institutional investors, financial analysts and media to a capital markets day in Stockholm on Wednesday 6 May 2020. As a service to international investors a follow-up meeting will be held in London on Thursday 7 May 2020.Presentations will be held by CEO Anders Nissen, CFO Liia Nõu and other members of Pandox’s management group with the objective to increase the understanding of Pandox’s business and business conditions. The capital markets day in Stockholm 6 May starts at 13:00 CEST and ends at 16:00 CEST. Lunch is served from 12:00 CEST. The venue is GT30,

Invitation to Investor’s Year-End Report 2019 presentation

CEO Johan Forssell and CFO Helena Saxon will present Investor’s Year-End Report 2019 for investors, analysts and the media at Arsenalsgatan 8C, Stockholm, on Wednesday, January 22, 2020 at 10:00 CET. The presentation will be in English and webcasted on www.investorab.com, where you can also ask questions. If you prefer to listen to the presentation, please call +44 33 33 00 08 04, +1 631 913 1422 or +46 8 566 426 51 and use the PIN code 85285988#. The presentation will be published on our website after the meeting, where the event will be available on demand. To attend the meeting,

Lifco acquires Rönvig Dental Manufacturing A/S

Lifco  has signed an agreement to acquire the Danish company Rönvig Dental Manufacturing A/S . The company is a niche manufacturer of dental products. In 2018, Rönvig reported net sales of approximately 30 MDKK. The company is based in Daugaard, Denmark and has 17 employees. The business will be consolidated in Business Area Dental. The acquisition will not have any significant effect on Lifco’s earnings or financial position in current financial year. Please visit www.ronvig.com for more information. For more information please contact:

Skanska builds advanced surgical pavilion in Manhasset, USA, for USD 238 M, about SEK 2.3 billion

Skanska has signed a contract with North Shore University Hospital (NSUH) to construct the new advanced surgical pavilion at their campus in Manhasset, New York, USA. The contract is worth USD 238 M, about SEK 2.3 billion, which will be included in the US order bookings for the fourth quarter 2019.The new 26,800 square-meter pavilion will replace and expand NSUH’s existing operating rooms, Cardiothoracic Intensive Care Unit, Neurological Intensive Care Unit, and provide core and shell space for future use. Also included in the overall square footage is a 2,940 square-meter parking deck.

Finavia airports had 26 million passengers in 2019 – a year of moderate growth in air traffic

2019 was a busy year at Finavia’s airports even though growth in air traffic was more moderate than in previous years. A total of 26 million passengers (+4,2%) travelled on scheduled and chartered flights.Last year, 21,9 million passengers (+4,9 %) travelled through Helsinki Airport, the largest international airport in Finland. The number of passengers using Finavia’s other airports increased to a total of 4,2 million (+0,6 %). Out of the larger airports, the number of passengers increased the most at Turku Airport (+22,6 %), Helsinki Airport (+4,9 %) and Rovaniemi Airport (+2,6 %). A

Sale of existing shares in Calliditas Therapeutics

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. PRESS RELEASE, January 10, 2020 Sofinnova Partners and Vivo Capital acquire 6% in Calliditas from Industrifonden and Investinor Stiftelsen Industrifonden ("Industrifonden") and Investinor AS ("Investinor") today announce that they have sold in aggregate approximately 2.3 million shares in Calliditas Therapeutics AB ("Calliditas" or the "Company"), listed on Nasdaq Stockholm, to leading international specialist investors Sofinnova Partners, investing

Invitation – Presentation of Q4 2019 Interim Report

Boliden will announce its Interim Report for the fourth quarter 2019 on Thursday 13 February at 07.45 (CET).  A press and analyst conference will be held on the same day at 09.30, which also can be followed via webcast and telephone.The report will be presented by Boliden’s President and CEO Mikael Staffas, and CFO Håkan Gabrielsson. Press and analyst conference Thursday, 13 FebruaryTime:         09.30 (CET)Venue:       Kapitel 8, Room DagermanAddress:    Klarabergsviadukten 90, Stockholm To participate, please call 5 minutes before the opening of the conference: •    from

Election of members to the board of directors and the nomination committee

The nomination committee has started the preparations for the annual general meeting of Webstep ASA for 2020. Input and proposals may be submitted to the nomination committee by 2 March 2020.The current directors were elected in 2019, and the term of office will expire at the annual general meeting 2020 for all five directors: Klaus-Anders Nysteen (chair), Toril Nag, Siw Ødegaard, Trond K. Johannessen and Bjørn Ivar Danielsen. The nomination committee comprises of John Bjerkan (chair), Trude Sleire (member) and Petter Tusvik (member). Petter Tusvik is up for election at the annual general

Kamux is expanding its operations: Kamux Niittykumpu in Espoo has opened

Kamux Corporation     Press release    10 January 2020 at 10:00 Kamux is expanding its operations: Kamux Niittykumpu in Espoo has opened Today, on Friday, Kamux has opened a new showroom in Niittykumpu in Espoo. The newest Kamux showroom is located near Niittykumpu subway station at Riihitontuntie 12. On December 2, 2019, Kamux announced acquiring the business of Autosilta from Jagro Oy. The transaction was completed on January 9, 2020. The newest Kamux showroom is located on former premises of Autosilta. Stronger foothold in the metropolitan area, wider selection for all

Talus implant approved in the EU

It took longer than expected for EpiSurf to get the new Talus implant system approved for marketing in Europe but it is now finally in place. We expect this to become a sizeable market over time, given the lack of alternatives and the number of patients suffering from defects in the talus. The company has not offered an over-abundance of details on the outlook for this market segment and we expect it to provide more information over the coming months.The talus implant system approved for marketing in the EU. It took slightly longer than expected to obtain approval for the implant system in

There are no items matching the current filter
There are no more items matching the current filter
Back to top